Chemomab Therapeutics Ltd. (NASDAQ:CMMB) Q1 2023 Earnings Call Transcript
Operator: Greetings, and welcome to Chemomab Therapeutics First Quarter 2023 Earnings Call and Corporate Update. At this time, all participants are in a listen-only-mode.
No. | Hedge Fund | Shares | Value | Activity | % Port |
---|---|---|---|---|---|
1. | OrbiMed Advisors Samuel Isaly | 2,241,273 | $2,045,162 | -1% | 0.04% |
2. | Ikarian Capital Neil Shahrestani | 213,392 | $196,320 | 0.03% | |
3. | Citadel Investment Group Ken Griffin | 62,402 | $57,410 | 0% | |
4. | Two Sigma Advisors John Overdeck And David Siegel | 18,100 | $16,516 | -53% | 0% |
Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
---|---|---|---|---|---|---|
$3.25 | 250 | Officer | 2,000 | 2022-03-16 | Filing | |
$3.30 | 250 | Officer | 1,750 | 2022-03-16 | Filing | |
$2.76 | 33 | Director | 1,433 | 2022-05-24 | Filing | |
$2.89 | 400 | Director | 1,400 | 2022-05-24 | Filing | |
$3.19 | 2,000 | Director | 12,409 | 2022-05-18 | Filing |
Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
---|---|---|---|---|---|---|
$4.51 | 70,524 | Large Shareholder | 2,241,274 | 2023-01-03 | Filing | |
$3.34 | 266,376 | Large Shareholder | 2,311,798 | 2023-01-03 | Filing | |
$5.03 | 6,100 | Officer, Director | 251,147 | 2023-01-03 | Filing | |
$5.03 | 7,700 | Officer, Director | 317,075 | 2023-01-03 | Filing | |
$2.00 | 2,409 | Director | 10,000 | 2022-11-16 | Filing |
No. | Name | Shares | Value | % Port |
---|---|---|---|---|
1. | 70,915 | $36,167 | 0% | |
2. | 56,305 | $28,716 | 0% | |
3. | 31,241 | $15,933 | 0% | |
4. | 29,047 | $14,814 | 0% | |
5. | 26,529 | $13,530 | 0% |